AIMS: To study the effects of two commonly used pre-amplifier filtering bandwidths on normal multifocal electroretinogram (mfERG) responses and their comparative abilities to detect retinal disease. METHODS: 103 standard mfERGs were recorded simultaneously in two channels with different pre-amplifier settings (10-100 Hz and 10-300 Hz) from one eye of each of 20 normal subjects, 17 diabetics with non-proliferative diabetic retinopathy (NPDR), and 12 diabetics without retinopathy. Signal to noise ratios (SNR) of the normal subjects' first order mfERGs were compared between channels. All subjects' amplitudes and implicit times were derived using a "template stretching" method. For comparison, implicit time was also measured using a "template sliding" method. mfERG amplitudes and implicit times were compared between the channels and among subject groups. RESULTS: Normal mean amplitudes and implicit times were similar for the two channels. However, normal 10-100 Hz recordings had significantly higher SNR and lower intersubject variability than 10-300 Hz recordings. In NPDR, the 10-100 Hz channel identified significantly more implicit time and amplitude abnormalities. In the diabetics without retinopathy, 10-100 Hz filtering identified significantly more implicit time abnormalities than 10-300 Hz filtering. For both filter settings, diabetic implicit times were more often abnormal than amplitudes. The 10-100 Hz channel was superior for both implicit time measurements. CONCLUSION: Standard mfERGs recorded from normal eyes and filtered 10-100 Hz contain less noise, higher SNR, and less intersubject variability than those filtered at 10-300 Hz. This underlies the finding that the 10-100 Hz filter setting identifies more retinal dysfunction than the 10-300 Hz setting.
AIMS: To study the effects of two commonly used pre-amplifier filtering bandwidths on normal multifocal electroretinogram (mfERG) responses and their comparative abilities to detect retinal disease. METHODS: 103 standard mfERGs were recorded simultaneously in two channels with different pre-amplifier settings (10-100 Hz and 10-300 Hz) from one eye of each of 20 normal subjects, 17 diabetics with non-proliferative diabetic retinopathy (NPDR), and 12 diabetics without retinopathy. Signal to noise ratios (SNR) of the normal subjects' first order mfERGs were compared between channels. All subjects' amplitudes and implicit times were derived using a "template stretching" method. For comparison, implicit time was also measured using a "template sliding" method. mfERG amplitudes and implicit times were compared between the channels and among subject groups. RESULTS: Normal mean amplitudes and implicit times were similar for the two channels. However, normal 10-100 Hz recordings had significantly higher SNR and lower intersubject variability than 10-300 Hz recordings. In NPDR, the 10-100 Hz channel identified significantly more implicit time and amplitude abnormalities. In the diabetics without retinopathy, 10-100 Hz filtering identified significantly more implicit time abnormalities than 10-300 Hz filtering. For both filter settings, diabetic implicit times were more often abnormal than amplitudes. The 10-100 Hz channel was superior for both implicit time measurements. CONCLUSION: Standard mfERGs recorded from normal eyes and filtered 10-100 Hz contain less noise, higher SNR, and less intersubject variability than those filtered at 10-300 Hz. This underlies the finding that the 10-100 Hz filter setting identifies more retinal dysfunction than the 10-300 Hz setting.
Authors: Michael F Marmor; Donald C Hood; David Keating; Mineo Kondo; Mathias W Seeliger; Yozo Miyake Journal: Doc Ophthalmol Date: 2003-03 Impact factor: 2.379
Authors: Karen Holopigian; William Seiple; Vivienne C Greenstein; Donald C Hood; Ronald E Carr Journal: Invest Ophthalmol Vis Sci Date: 2002-07 Impact factor: 4.799
Authors: Thomas A Ciulla; Alon Harris; Paul Latkany; Heidi C Piper; Oliver Arend; Hana Garzozi; Bruce Martin Journal: Acta Ophthalmol Scand Date: 2002-10
Authors: Marcus A Bearse; Anthony J Adams; Ying Han; Marilyn E Schneck; Jason Ng; Kevin Bronson-Castain; Shirin Barez Journal: Prog Retin Eye Res Date: 2006-09-01 Impact factor: 21.198
Authors: Anna A Ledolter; Sophie A Kramer; Margarita G Todorova; Andreas Schötzau; Anja M Palmowski-Wolfe Journal: Doc Ophthalmol Date: 2012-12-08 Impact factor: 2.379
Authors: Marilyn E Schneck; Marcus A Bearse; Ying Han; Shirin Barez; Carl Jacobsen; Anthony J Adams Journal: Doc Ophthalmol Date: 2004-05 Impact factor: 2.379
Authors: Iryna A Falkenstein; Dirk-Uwe Bartsch; Stanley P Azen; Laurie Dustin; Alfredo A Sadun; William R Freeman Journal: Am J Ophthalmol Date: 2008-02-15 Impact factor: 5.258
Authors: Michael H Goldbaum; Irina Falkenstein; Igor Kozak; Jiucang Hao; Dirk-Uwe Bartsch; Terrance Sejnowski; William R Freeman Journal: Trans Am Ophthalmol Soc Date: 2008
Authors: Kevin W Bronson-Castain; Marcus A Bearse; Jessica Neuville; Soffia Jonasdottir; Barbara King-Hooper; Shirin Barez; Marilyn E Schneck; Anthony J Adams Journal: Retina Date: 2009-05 Impact factor: 4.256
Authors: Kevin W Bronson-Castain; Marcus A Bearse; Ying Han; Marilyn E Schneck; Shirin Barez; Anthony J Adams Journal: Invest Ophthalmol Vis Sci Date: 2007-11 Impact factor: 4.799
Authors: Wendy W Harrison; Marcus A Bearse; Jason S Ng; Shirin Barez; Marilyn E Schneck; Anthony J Adams Journal: Doc Ophthalmol Date: 2009-03-26 Impact factor: 2.379